Abstract
Introduction
Oral baclofen is commonly used for spasticity management, especially with neurogenic bladder in spinal cord injury (SCI). A less common side effect of baclofen is transient alterations of consciousness, which can easily be confused for altered mental status secondary to orthostatic hypotension in SCI.
Case presentation
A 43-year-old man with an acute SCI secondary to an aortic dissection was found to have episodes of confusion after titrating oral baclofen from 5 mg three times per day to 10 mg three times per day at an acute rehabilitation facility. Orthostatic hypotension was initially suspected as the cause of transient alterations of consciousness; however, he was never found to be hypotensive during these episodes. His confusion resolved several days after discontinuation of baclofen.
Discussion
Although, confusion and lightheadedness in SCI are commonly caused by orthostatic hypotension, it is important for physicians to be cognizant of baclofen’s side effects, which increase in the setting of acute kidney injury (AKI). If an adverse effect is suspected, baclofen should be tapered while remaining observant for signs of baclofen withdrawal, which can be life-threatening. This case report is a reminder for clinicians to be aware of the uncommon adverse effects of baclofen when initiating therapy in SCI, especially in patients with AKI and neurogenic bladders.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Change history
18 August 2023
A Correction to this paper has been published: https://doi.org/10.1038/s41394-023-00601-6
References
Ghanavatian S, Derian A Baclofen. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur J Clin Pharm. 1989;37:181–4.
Simon N, Franchitto N, Rolland B. Pharmacokinetic studies of baclofen are not sufficient to establish an optimized dosage for management of alcohol disorder. Front Psychiatry. 2018;9:485.
Knutsson E, Lindblom U, Mårtensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci. 1974;23:473–84.
Wolf E, Kothari NR, Roberts JK, Sparks MA. Baclofen toxicity in kidney disease. Am J Kidney Dis. 2018;71:275–80.
Su W, Yegappan C, Carlisle EJF, Clase CM. Reduced level of consciousness from baclofen in people with low kidney function. BMJ 2009;339:b4559.
Lee TH, Chen SS, Su SL, Yang SS. Baclofen intoxication: report of four cases and review of the literature. Clin Neuropharmacol. 1992;15:56–62.
Green LB, Nelson VS. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil. 1999;80:1600–4.
Alvis BD, Sobey CM. Oral Baclofen withdrawal resulting in progressive weakness and sedation requiring intensive care admission. Neurohospitalist 2017;7:39–40.
Illman A, Stiller K, Williams M. The prevalence of orthostatic hypotension during physiotherapy treatment in patients with an acute spinal cord injury. Spinal Cord. 2000;38:741–7.
Albright AL. Topical review: Baclofen in the treatment of cerebral palsy. J Child Neurol. 1996;11:77–83.
Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl. 1997;6:S92–120.
Imbert B, Alvarez J-C, Simon N. Anticraving effect of Baclofen in alcohol-dependent patients. Alcohol Clin Exp Res. 2015;39:1602–8.
Aisen ML, Dietz MA, Rossi P, Cedarbaum JM, Kutt H. Clinical and pharmacokinetic aspects of high dose oral baclofen therapy. J Am Paraplegia Soc. 1992;15:211–6.
Ragnarsson KT, Krebs M, Naftchi NE, Demeny M, Sell GH, Lowman EW, et al. Effects of head-up tilt on glomerular filtration rate and renal plasma flow in spinal man. In: Naftchi NE, editor. Spinal Cord Injury. Dordrecht: Springer Netherlands; 1982. p. 233–40.
Chen KS, Bullard MJ, Chien YY, Lee SY. Baclofen toxicity in patients with severely impaired renal function. Ann Pharmacother. 1997;31:1315–20.
Ijaz M, Tariq H, Kashif M, Marquez JG. Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease. Am J Case Rep. 2015;16:232–5.
Dahlin PA, George J. Baclofen toxicity associated with declining renal clearance after ibuprofen. Drug Intell Clin Pharm. 1984;18:805–8.
Kiel LB, Hoegberg LCG, Jansen T, Petersen JA, Dalhoff KP. A nationwide register-based survey of baclofen toxicity. Basic Clin Pharm Toxicol. 2015;116:452–6.
Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics 1998;101:1045–8.
Wu V-C, Lin S-L, Lin S-M, Fang C-C. Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study. Nephrol Dial Transpl. 2005;20:441–3.
Leo RJ, Baer D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics 2005;46:503–7.
Peng CT, Ger J, Yang CC, Tsai WJ, Deng JF, Bullard MJ, et al. Prolonged severe withdrawal symptoms after acute-on-chronic baclofen overdose. J Toxicol Clin Toxicol. 1998;36:359–63.
Kirubakaran V, Mayfield D, Rengachary S. Dyskinesia and psychosis in a patient following baclofen withdrawal. Am J Psychiatry. 1984;141:692–3.
D’Aleo G, Cammaroto S, Rifici C, Marra G, Sessa E, Bramanti P, et al. Hallucinations after abrupt withdrawal of oral and intrathecal baclofen. Funct Neurol. 2007;22:81–8.
Cunningham JA, Jelic S. Baclofen withdrawal: a cause of prolonged fever in the intensive care unit. Anaesth Intensive Care. 2005;33:534–7.
Harrison SA, Wood CA Jr. Hallucinations after preoperative baclofen discontinuation in spinal cord injury patients. Drug Intell Clin Pharm. 1985;19:747–9.
Ross JC, Cook AM, Stewart GL, Fahy BG. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care. 2011;14:103–8.
Terrence CF, Fromm GH. Complications of baclofen withdrawal. Arch Neurol. 1981;38:588–9.
Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012;50:107–11.
Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesth Analg. 1995;80:1054–6.
Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil. 2003;84:638–42.
Saissy JM, Vitris M, Demazière J, Seck M, Marcoux L, Gaye M, et al. Flumazenil counteracts intrathecal baclofen-induced central nervous system depression in tetanus. Anesthesiology 1992;76:1051–3.
Funding
TJP is funded by NINDS F31 NS089303.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Informed consent
Patient gave verbal informed consent on 8/25/2020.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pisano, T.J., Ace, J. & Hon, B. Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report. Spinal Cord Ser Cases 8, 56 (2022). https://doi.org/10.1038/s41394-022-00511-z
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41394-022-00511-z
This article is cited by
-
Baclofen/vancomycin
Reactions Weekly (2022)
